Ossium Health key facts
as of Oct 2026- Developer of stem cell-based therapies designed to improve the health, vitality, and longevity of human beings through bioengineering.
- Ossium Health is valued at approximately $325.0M as of Oct 2026, set at its later-stage round, Jul 2023; nothing has traded since, per PrivateMarketView’s mark.
- It has raised $125.8M across 1 recorded rounds; the latest was Early Stage VC ($10.4M) in May 2018.
- Notable investors include Alumni Ventures, General Catalyst, Gaingels, Village Global, First Round Capital — 30 tracked in total.
- Ossium Health has filed 1 Form D with the SEC, most recently May 2018 ($10.4M sold to 12 investors).
- Status: Privately Held (backing).
Valued at $325.0M at its later-stage round, Jul 2023. Nothing has traded since.
- ·The complete investor list: 30 names
- ·Watch Ossium Health: the Monday email on marks, rounds and moves
Ossium Health funding rounds
1 roundsWho backs Ossium Health
30+Ossium Health valuation
Ossium Health was valued at $325 million at its later-stage round in Jul 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Ossium Health raised?
Ossium Health has raised $126 million in total; 1 of its rounds is on record. The largest on record was a $10.4 million early-stage round in May 2018.
Ossium Health has filed 1 Form D with the SEC, most recently in May 2018 ($10.4 million sold to 12 investors).
Ossium Health investors
30 investors are on record for Ossium Health, including Alumni Ventures, General Catalyst, Gaingels and Village Global. By type, the record holds 10 venture capital firms and 1 angel investor. The early-stage round in May 2018 drew 12 investors.
About Ossium Health
Developer of stem cell-based therapies designed to improve the health, vitality, and longevity of human beings through bioengineering. The company's therapies cure leukemia and other blood diseases, improve organ transplantation, treat radiation poisoning, and heal tissue damage, enabling healthcare professionals to improve a new paradigm for cell therapy development by bringing the deceased donor transplant ecosystem into the fight against diseases of the blood and immune systems.
- Sector
- Healthcare
- HQ
- San Francisco, CA, United States
- Founded
- 2016
- Employees
- 92
- Website
- ossiumhealth.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.